Bladder Cancer

Showing NaN - NaN of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

Bladder Cancer, Radical Cystectomy Trial in Ann Arbor (CLEAR Care Companion (CC) application)

Recruiting
  • Bladder Cancer
  • Radical Cystectomy
  • CLEAR Care Companion (CC) application
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 9, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Bladder Cancer Trial in United States (N-803 and BCG, N-803)

    Recruiting
    • Bladder Cancer
    • Anchorage, Alaska
    • +31 more
    Oct 26, 2022

    Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

    Completed
    • Bladder Cancer
    • Urothelial Carcinoma
    • Birmingham, Alabama
    • +34 more
    Jul 7, 2022

    Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)

    Completed
    • Bladder Cancer
    • induction cisplatin
    • +13 more
    • Atlanta, Georgia
    • +10 more
    May 23, 2022

    Bladder Cancer Trial in Worldwide (Gemcitabine, E7389, Cisplatin)

    Terminated
    • Bladder Cancer
    • Birmingham, Alabama
    • +41 more
    Feb 3, 2022

    Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

    Recruiting
    • Pancreatic Cancer
    • +49 more
      • Colorado Springs, Colorado
      • +80 more
      Feb 22, 2022

      Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)

      Active, not recruiting
      • Bladder Cancer
      • Birmingham, Alabama
      • +565 more
      Dec 3, 2021

      Bladder Cancer Trial in Canada, United States (Vicinium)

      Active, not recruiting
      • Bladder Cancer
      • Vicinium
      • Birmingham, Alabama
      • +69 more
      Jun 10, 2021

      Bladder Cancer Trial in Canada, United States (drug, procedure, radiation)

      Completed
      • Bladder Cancer
      • Birmingham, Alabama
      • +228 more
      Oct 19, 2020

      Bladder Cancer Trial in United States (gemcitabine HCl, )

      Completed
      • Bladder Cancer
      • gemcitabine hydrochloride
      • placebo
      • Little Rock, Arkansas
      • +69 more
      Jan 8, 2020

      Bladder Cancer Trial in Ann Arbor (Baseline Strength Test, Exercise)

      Completed
      • Bladder Cancer
      • Baseline Strength Test
      • Exercise
      • Ann Arbor, Michigan
        University of Michigan
      Aug 6, 2019

      Urinary Sediment in Detecting Bladder Cancer

      Completed
      • Bladder Cancer
      • loss of heterozygosity analysis
      • +6 more
      • Birmingham, Alabama
      • +12 more
      Feb 6, 2019

      Impaired Survival in Elderly Bladder Cancer Patients Opting for

      Completed
      • Bladder Cancer
        • Ann Arbor, Michigan
          University of Michigan
        Jul 25, 2017

        Urothelial Carcinoma, Bladder Cancer Trial in Ann Arbor (Sunitinib)

        Terminated
        • Urothelial Carcinoma
        • Bladder Cancer
        • Ann Arbor, Michigan
          University of Michigan
        May 26, 2017

        Bladder Cancer Trial in Canada, United States (cisplatin, doxorubicin HCl, methotrexate)

        Terminated
        • Bladder Cancer
        • Glendale, Arizona
        • +73 more
        May 10, 2017

        Non-Small-Cell Lung Carcinoma, Prostate Cancer, Bladder Cancer Trial in Ann Arbor (vorinostat (suberoylanilide hydroxamic acid),

        Terminated
        • Non-Small-Cell Lung Carcinoma
        • +3 more
        • vorinostat (suberoylanilide hydroxamic acid)
        • docetaxel
        • Ann Arbor, Michigan
          University of Michigan Comprehensive Cancer Center
        Dec 1, 2016

        Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine

        Terminated
        • Bladder Cancer
        • +2 more
        • Mobile, Alabama
        • +91 more
        Jul 8, 2016

        Bladder Cancer Trial in United States (filgrastim, cisplatin, doxorubicin HCl)

        Completed
        • Bladder Cancer
        • filgrastim
        • +3 more
        • Scottsdale, Arizona
        • +284 more
        Jul 12, 2016

        Bladder Cancer Trial in Canada, United States (multivitamin, Placebo)

        Completed
        • Bladder Cancer
        • multivitamin
        • Placebo
        • Scottsdale, Arizona
        • +16 more
        Jul 12, 2016